Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CEA (clone F39Q-1G1G). We employs the Adenovirus (trc-BFP-LEF/TCF-EcoRI) vector components and the SynExpress system of the Introns Knockout/Positive feedback for a robust and sustained response against cancers.
Host
human
Target
CEA
Clone
F39Q-1G1G
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
BFP
Promoter
trc
Effector Gene
LEF/TCF
Insertion Sites
EcoRI
Gene Modification
Knockout
Modification Domain
Introns
Carrier Type
Adenovirus
Transformation Accuracy
0.85
Cell Culture
Suspension Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.